This was specifically demonstrated in mice in which the hepatocyte-restricted expression of the human mutant variant of APP displayed peripheral metabolism of Aβ peptides and associated neurovascular inflammation, CNS neurodegeneration, and memory impairment. The gene discussed is APP; the disease is memory impairment.